| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Early Stage, Seed |
| Investing | Netherlands |
NextGen Ventures, also known as NXG or NXG Ventures, is a venture capital firm that focuses on nurturing early-stage digital health and medtech startups. They invest their capital in pioneering hardware and software innovations that aim to provide more efficient and improved healthcare. Specializing in seed and early-stage investment phases, NextGen Ventures supports startups in scaling their operations, enhancing their impact, and driving significant advancements in healthcare efficiency and effectiveness.
They have a geographic focus on companies located across the Netherlands, Germany, and Belgium, actively leveraging their resources and expertise to help these startups achieve their full potential. The firm targets startups that address unmet medical needs and creates a positive impact aligned with the Quadruple Aim Framework, which includes enhancing patient experience, improving population health, reducing costs, and improving the work life of healthcare providers. NextGen Ventures stands out due to their decade of proven expertise in the healthcare sector and often acts as the first institutional investor for healthcare startups.
Their active involvement extends beyond funding as they also provide dedicated support, access to an extensive network, and a commitment to impactful innovation. The firm’s current portfolio includes companies like AMT-Medical, Attendi, Elanza, and more, which are part of their mission to transform visionary ideas into realities that drive meaningful change in healthcare.
As part of a broader organization, NextGen Ventures executes its investment activities through the investment funds NextGen Ventures B.V., a limited liability company, and NextGen Ventures 2 C.V., a limited liability partnership, both governed by Dutch law and with their registered office in Ede, the Netherlands.

